CTOs on the Move

MIVI Neuroscience

www.mivineuro.com

 
MIVI Neuroscience, (MIVI) is an innovative medical device company that aims to achieve life-giving results for an increasing number of patients experiencing acute ischemic stroke (AIS).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.mivineuro.com
  • 6545 City West Parkway
    Eden Prairie, MN USA 55344
  • Phone: 952.944.3834

Executives

Name Title Contact Details
Matt Ogle
Chief Technology Officer Profile

Funding

MIVI Neuroscience raised $45M on 12/29/2020
MIVI Neuroscience raised $35M on 01/21/2021

Similar Companies

Active Implants Corporation

Active Implants Corporation is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ACE Surgical Supply Company

ACE Surgical Supply Company is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clinicon Corporation

Clinicon Corporation is a Oceanside, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PetVivo

PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.

Benvenue Medical

Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by InterWest Partners, Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.